{
    "Trade/Device Name(s)": [
        "Premier\u00ae HpSA\u00ae Flex"
    ],
    "Submitter Information": "Meridian Bioscience, Inc.",
    "510(k) Number": "K230901",
    "Predicate Device Reference 510(k) Number(s)": [
        "K182559",
        "K053335",
        "K983255",
        "K980076"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "LYR"
    ],
    "Summary Letter Date": "July 3, 2023",
    "Summary Letter Received Date": "March 31, 2023",
    "Submission Date": "March 31, 2023",
    "Regulation Number(s)": [
        "21 CFR 866.3110"
    ],
    "Regulation Name(s)": [
        "Campylobacter fetus serological reagents"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Helicobacter pylori antigens"
    ],
    "Specimen Type(s)": [
        "Unpreserved stool",
        "Stool preserved in Cary-Blair transport media",
        "Stool preserved in Culture and Sensitivity (C&S) transport media"
    ],
    "Specimen Container(s)": [
        "Transport media (Cary-Blair)",
        "Transport media (Culture and Sensitivity)"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Enzyme immunoassay (EIA)",
        "Microwell-based immunoassay"
    ],
    "Methodologies": [
        "Qualitative detection",
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for Premier HpSA Flex microwell-based enzyme immunoassay kit for qualitative detection of Helicobacter pylori antigens in unpreserved or preserved human stool specimens.",
    "Indications for Use Summary": "In vitro qualitative enzyme immunoassay for detection of Helicobacter pylori antigens in unpreserved or preserved human stool specimens, to aid in diagnosis and monitoring of H. pylori infection during and after therapy.",
    "fda_folder": "Microbiology"
}